Singleron Biotechnologies
PrivateLast Round
Series B
Nov 8, 2021
Total Funding Raised
$170M
Company Overview
Singleron Biotechnologies operates in Healthcare & Life Sciences and is based in Nanjing. Its latest recorded funding round was a Series B round in November 2021.
Singleron Biotechnologies is a biotechnology company that develops single-cell multi-omics analysis technologies, providing molecular diagnostic products and automated equipment for clinical diagnosis, health management, and drug development.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Biotech Equipment, Precision Medicine, Drug Discovery
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting, Usage-Based SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Singleron Biotechnologies Comparables
Compare Singleron Biotechnologies with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Beijing SeekGene BioSciences Co., Ltd. | 88% | |
| BioSkryb Genomics | 85% | |
| Mission Bio | 84% |
For institutional investors. Book with your work email.
Singleron Biotechnologies Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Nov 8, 2021 | ||||
| Series A2 | Dec 29, 2020 | ||||
| Series A1 | Nov 9, 2020 | ||||
| Series A | Sep 6, 2020 | ||||
| Pre-Series A | Jun 20, 2019 | ||||
Seed | May 1, 2018 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Singleron Biotechnologies Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| CDH Investments | Series A1, Series A, Series B |
| Lake Bleu Capital | Series B |
| Firstred Capital | Series B |
| MSA Capital | Series B |
| Frees Fund | Pre-Series A, Seed |
| ARCH Venture Partners | Series A, Series B |
| CDG Capital (晨岭资本) | Series A |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 9, 2025
Launched Tensor for single cell sequencing automation with Hamilton Bonaduz AG.
- Apr 9, 2025
Partnered with Hamilton Bonaduz AG to launch Tensor.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- is_developingOct 23, 2026
Singleron Biotechnologies Ltd. is developing single-cell multi-omics capabilities through AD-Omics, IHLAD's joint venture with Singleron Biotechnologies Ltd., to support biological research and precision medicine in United Arab Emirates.
For institutional investors. Book with your work email.
Singleron Biotechnologies Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Singleron Biotechnologies's valuation, stock price, and market status.
Is Singleron Biotechnologies a public or private company?
Singleron Biotechnologies is a private company.
What is the current stock price of Singleron Biotechnologies?
Singleron Biotechnologies is a private company, so its shares have no public market price. Caplight tracks Singleron Biotechnologies's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Singleron Biotechnologies worth (valuation)?
Valuation information for Singleron Biotechnologies is not publicly available.
Can I buy Singleron Biotechnologies stock?
Singleron Biotechnologies shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Singleron Biotechnologies's last funding round?
Singleron Biotechnologies's most recent funding round was Series B on November 8, 2021.
Who are the main investors in Singleron Biotechnologies?
Key investors in Singleron Biotechnologies include Lake Bleu Capital, Firstred Capital, Lilly Asia Ventures, Oriza Seed Venture Capital, Sherpa Healthcare Partners.
Will Singleron Biotechnologies IPO soon?
No public IPO plans have been announced for Singleron Biotechnologies.
How can I track Singleron Biotechnologies secondary market activity?
Caplight tracks bids, offers, and trades in Singleron Biotechnologies's shares on secondary markets.